APP and Alzheimer disease: CSF Abeta42 levels are significantly reduced in AD patients compared to normal controls [11,12,13] due to its increased deposition in the amyloid plaques and a significant correlation has been found between increased amounts of amyloid plaques in the cortex and hippocampus and reduced CSF Abeta42 levels [14,15].